APA (7th ed.) Citation

Franziska Schmidt, Miriam Erlacher, Charlotte Niemeyer, Dirk Reinhardt, & Jan-Henning Klusmann. (2022). Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Franziska Schmidt, Miriam Erlacher, Charlotte Niemeyer, Dirk Reinhardt, and Jan-Henning Klusmann. Leukoreductive Response to the Combination of Sorafenib and Chemotherapy in Hyperleukocytosis of FLT3-ITD Mutated Pediatric AML. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Franziska Schmidt, et al. Leukoreductive Response to the Combination of Sorafenib and Chemotherapy in Hyperleukocytosis of FLT3-ITD Mutated Pediatric AML. Frontiers Media S.A., 2022.